DiLiCre2.0 mouse model: An advanced genome-editing tool to induce mutagenesis in vivo with high spatio-temporal

Miguel Vizoso1

  • 1Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, CX, the Netherlands; Medical Cell Biology Department, Uppsala University, Uppsala, Sweden.

Methods in Cell Biology
|February 22, 2026
PubMed

Insights

Researchers developed a novel mouse model for studying cancer initiation. This innovative tool uses light-targeted mutagenesis to induce early tumorigenesis in single cells, improving the study of cancer development.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Transgenic mouse models are crucial for studying cancer development in vivo.
  • Current models often fail to replicate the spatially restricted, single-cell origin of human cancers.
  • This discrepancy limits the translational relevance of existing models for understanding human tumor initiation.

Purpose of the Study:

  • To develop an innovative mouse model for studying early tumorigenesis.
  • To overcome the limitations of existing models in replicating human cancer initiation.
  • To achieve high spatio-temporal resolution in studying tumor initiation processes.

Main Methods:

  • Development of a novel mouse model for inducing early tumorigenesis.
  • Utilizing light-targeted mutagenesis for precise genetic manipulation.
  • Achieving single-cell resolution for studying tumor initiation in vivo.

Main Results:

  • The developed model enables the induction of early tumorigenesis with high spatio-temporal control.
  • This approach allows for the study of tumor initiation from single mutated cells.
  • The model provides a more accurate in vivo system for investigating cancer origins.

Conclusions:

  • The novel light-targeted mutagenesis mouse model accurately replicates key aspects of human cancer initiation.
  • This research enhances our understanding of cancer mechanisms at their inception.
  • The model offers a powerful tool for future cancer research and therapeutic development.